Hines to up exposure to life sciences real estate
US privately-held developer-investor Hines has unveiled plans to increase its exposure to life sciences properties on the back of strong fundamentals for this market segment.
You have now reached your article limit
Already have an IPE Real Assets account? Sign in
PropertyEU has merged with IPE Real Assets
If you had a PropertyEU account, simply reset your password to get access to IPE Real Assets.
New users can Register for free today for access to the PropertyEU Archive and IPE Real Assets.
Registration also includes access to IPE
Five reasons to register today
- Access IPE Real Assets articles
- Daily news alerts and updates
- Track what the world’s leading institutional investors are doing
- Learn about the latest industry research and market analysis
- Comprehensive archive of data and intelligence on investors and fund managers, including the PropertyEU Archive
Copyright © 1997–2025 IPE International Publishers Limited, Registered in England, Reg No. 3233596, VAT No. 685 1784 92. Registered Office: 1 Kentish Buildings, 125 Borough High Street, London SE1 1NP